FATE — Fate Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual balance sheet for Fate Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	483	616	436	315	279
Net Total Accounts Receivable
Net Total Receivables	5.51	8.68	38.5	1.83	3.54
Prepaid Expenses
Total Current Assets	494	633	502	332	292
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	99.4	162	176	159	111
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	622	921	706	506	441
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	85.6	81.3	114	39.1	38.5
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	238	243	222	138	122
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	384	679	484	368	319
Total Liabilities & Shareholders' Equity	622	921	706	506	441
Total Common Shares Outstanding
Total Preferred Shares Outstanding